Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenwu He

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|September 26, 2023
Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant ChemoradiotherapyYehan Zhou, Wenwu He, Peng Guo, et al.
Frontiers in Oncology|October 18, 2021
MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell CarcinomaQiyu Luo, Wenwu He, Tianqin Mao, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2024
Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysisKexun Li, Changding Li, Xin Nie, et al.
Frontiers in Immunology|June 20, 2022
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory StudyWenwu He, Chenghao Wang, Lei Wu, et al.
Frontiers in Immunology|March 6, 2023
The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysisWenwu He, Chenghao Wang, Changding Li, et al.
Annals of Surgical Oncology|February 19, 2024
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival AnalysisKexun Li, Kunyi Du, Changding Li, et al.
Cancer Medicine|November 30, 2025
Involved-Field Irradiation Versus Elective Nodal Irradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant ChemoradiotherapyXiaoding Zhou, Ying Liu, Jie Zhu, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 22, 2024
Long-term outcomes of intrathoracic versus cervical anastomosis after esophagectomy: A large-scale propensity score matching analysisKexun Li, Simiao Lu, Longlin Jiang, et al.
BMC Cancer|December 1, 2023
Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective studyQiang Zhou, Qiao He, Wenwu He, et al.
Journal of Thoracic Disease|January 12, 2026
Quality of life and survival of achieving textbook outcome for resectable esophageal squamous cell carcinomaXinming Nie, Kaixin Zhao, Qin Xie, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|September 26, 2023
Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant ChemoradiotherapyYehan Zhou, Wenwu He, Peng Guo, et al.
Frontiers in Oncology|October 18, 2021
MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell CarcinomaQiyu Luo, Wenwu He, Tianqin Mao, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2024
Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysisKexun Li, Changding Li, Xin Nie, et al.
Frontiers in Immunology|June 20, 2022
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory StudyWenwu He, Chenghao Wang, Lei Wu, et al.
Frontiers in Immunology|March 6, 2023
The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysisWenwu He, Chenghao Wang, Changding Li, et al.
Annals of Surgical Oncology|February 19, 2024
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival AnalysisKexun Li, Kunyi Du, Changding Li, et al.
Cancer Medicine|November 30, 2025
Involved-Field Irradiation Versus Elective Nodal Irradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant ChemoradiotherapyXiaoding Zhou, Ying Liu, Jie Zhu, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 22, 2024
Long-term outcomes of intrathoracic versus cervical anastomosis after esophagectomy: A large-scale propensity score matching analysisKexun Li, Simiao Lu, Longlin Jiang, et al.
BMC Cancer|December 1, 2023
Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective studyQiang Zhou, Qiao He, Wenwu He, et al.
Journal of Thoracic Disease|January 12, 2026
Quality of life and survival of achieving textbook outcome for resectable esophageal squamous cell carcinomaXinming Nie, Kaixin Zhao, Qin Xie, et al.
Pageof 7